Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Q8CE
|
|||
Former ID |
DNC010835
|
|||
Drug Name |
4-(2-(3-tert-Butylphenylamino)ethyl)-1H-imidazole
|
|||
Synonyms |
CHEMBL1096517; 4-(2-(3-tert-Butylphenylamino)ethyl)-1H-imidazole
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H21N3
|
|||
Canonical SMILES |
CC(C)(C)C1=CC(=CC=C1)NCCC2=CN=CN2
|
|||
InChI |
1S/C15H21N3/c1-15(2,3)12-5-4-6-13(9-12)17-8-7-14-10-16-11-18-14/h4-6,9-11,17H,7-8H2,1-3H3,(H,16,18)
|
|||
InChIKey |
LRIVTYQQFCXAFC-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Histamine receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | Monoamine Transport | |||
GPCRs, Class A Rhodopsin-like | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active hi... J Med Chem. 2010 May 13;53(9):3840-4. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.